Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia

NCT01137747 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Carfilzomib

Sponsor

Washington University School of Medicine